Tailored radiation blasts early lung tumors with precision

NCT ID NCT07167459

First seen Oct 31, 2025 · Last updated Jun 10, 2026 · Updated 32 times

Summary

This study tests a personalized, high-dose radiation therapy (SBRT) for people with early-stage peripheral non-small cell lung cancer who cannot have surgery or choose not to. The goal is to see if this tailored approach controls the tumor and helps patients live longer with fewer side effects. About 251 participants will be followed for 3 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY-STAGE PERIPHERAL NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin 300060

    Tianjin, Tianjin Municipality, 300381, China

  • Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin 300060

    Tianjin, Tianjin Municipality, China

Conditions

Explore the condition pages connected to this study.